*Correspondence: Predrag Sikiric, [email protected] This article was submitted to Gastrointestinal and Hepatic Pharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Two commonly discussed treatments are PRP (Platelet-Rich Plasma) therapy and Cortisone injections
Kidney or liver issues, while rare, have been reported with unregulated or contaminated products
It has been demonstrated that ferroptosis inhibitors, including deferoxamine and ferrostatin-1, can mitigate the advancement of associated diseases by preventing ferroptosis [13,14,15,16]
Standard practice for this class of research compound includes verifying identity and purity prior to release, and, where available, issuing batch-specific documentation such as a Certificate of Analysis (COA) so researchers can independently verify the material they receive
Recent animal studies have examined how to treat senescent cells with therapies such as the FOXO4-DRI peptide
